KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Depreciation & Amortization (CF) (2016 - 2025)

Astrana Health (ASTH) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $16.4 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 101.83% to $16.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.7 million through Dec 2025, up 63.82% year-over-year, with the annual reading at $45.7 million for FY2025, 63.82% up from the prior year.
  • Depreciation & Amortization (CF) hit $16.4 million in Q4 2025 for Astrana Health, up from $15.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $16.4 million in Q4 2025 to a low of $4.1 million in Q4 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $6.3 million across 5 years, with a median of $4.7 million in 2021.
  • Biggest five-year swings in Depreciation & Amortization (CF): decreased 10.74% in 2021 and later soared 114.7% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $4.4 million in 2021, then dropped by 7.91% to $4.1 million in 2022, then grew by 20.65% to $4.9 million in 2023, then skyrocketed by 65.77% to $8.1 million in 2024, then skyrocketed by 101.83% to $16.4 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for ASTH at $16.4 million in Q4 2025, $15.6 million in Q3 2025, and $6.9 million in Q2 2025.